Tag: PZOO

Blue Horseshoe Stocks: Options Review & More

Options Review – Yesterday’s Big Winners
___
For some of our readers that may not have previously understood why we like to mix options-trading ideas in with our equities ideas, yesterday’s session served as an excellent example. All three of the stocks whose options chains we were tracking provided folks with substantial opportunities for lucrative daytrades. Here’s a breakdown:
___

Ford Motor Co. (F) – On the heels of the revelation that Ford had set revenue records and beat earning expectations for Q2, we saw the chance to leverage the resultant action on the chart to our great advantage. The range of contracts that we flagged for observation was the F Weekly $14.50 and $15 Calls. As the $15’s fell just shy of being pushed into the money, the main thrust of the action was in the $14.50’s. Those contracts went big, with a surge from a low of .18 all the way up to .42; an intraday spike of 133% We’ll be on the lookout for potential dip-and-rip scenarios in Ford to create the possibility of further opportunities as the week wears on.
___

Pfizer, Inc. PFE – it was also a beat on earnings that propelled our PFE ideas to substantial intraday gains. Our specific area of interest were the PFE Weekly $34.50 and $35 Calls. The $34.50’s made an impressive move from .26-.88 for total possible gains of 238% and the $35’s really performed with a monster 410% run from .10-.51!

___

Baidu, Inc. BIDU – In a departure from our standard options M.O., we identified a chance to play some Puts as BIDU was taking an absolute shellacking after its own earnings missed the mark. The downfall continued throughout the session, and fueled the success of our observed contracts, which were the BIDU Weekly Puts in the $180-175 Range. The trading ranges and maximum gains on all three sets of contracts were as follows:

$180 Calls – Daily Range: 8.00-18.05 – Max Gain: 126%
$177.50 Calls – Daily Range: 5.20- 14.90 – Max Gain: 187%
$175 Calls – Daily Range: 3.88-13.10 – Max Gain: 238%

___

MORE IDEAS

Cheers to any of our readers who were able to parlay those ideas into some solid intraday profits. We’ve got some fresh ideas to monitor during today’s session as well:

Twitter, Inc. TWTR Weekly $34-32 Puts

Micron Technologies, Inc. MU Weekly $19-20.50 Calls

Pazoo, Inc. PZOO

We also want to make a quick note of the PZOO news that hit wires right at market open yesterday. The storyline we’ve been continuously following with Pazoo regarding the company’s foray into the medical marijuana testing business received a significant update.

Pazoo subsidiary, Harris Lee, LLC has signed an agreement that will facilitate the takeover of an operational testing facility in Colorado, be sure to check out the PR below:

WHIPPANY, N.J., July 28, 2015 /PRNewswire/ — Pazoo, Inc. (OTCPink Symbol: PZOO) is pleased to announce that wholly-owned subsidiary Harris Lee, LLC has signed a sublicense, and loan agreement with Harris Lee Colorado, LLC (HLC). These agreements now allow HLC to meet the in state residency requirement and provide for the necessary funding to take over the testing lab, expand the marketing and employment base and begin the expansion of the operations.

All agreements will be forwarded on to the Colorado MED for review. A small redesign of the layout of the laboratory will be undertaken to increase the efficiency and functionality of the facility. Over the past 2 months the Pazoo team has made contact with numerous growers and has gotten firm commitments from these growers to test with HLC once the State review is complete. >> FULL PR

Extended Watchlist:
CLF, SZYM, GALE, SONS, DGLY, CETV

Blue Horseshoe Stocks: Fresh Options Ideas & More

Pazoo Inc. PZOO

PZOO has been progressing well in the past several sessions since we last touched base with the stock a couple of weeks ago. We had just received word from the company that its wholly-owned CannabisKing Distribution subsidiary had struck two significant deals (Links to PR’s below), and witnessed a two-session swing of 74% as a result.

After regrouping and bouncing off of a low of .0046 (07/13), PZOO has made continuously higher lows for the rest of this month, and pushed its PPS back to the current range (.006-.007). We’ve provided the following snapshot illustrating the current bullish characteristics of the chart.

We’ll be on the lookout for further updates regarding the many irons PZOO currently has in the fire, and you can be sure that we’ll pass them along as the stories develop.

Fresh Options Ideas

As we approach midweek with earnings drops in full swing, we’re going to formulate a few corresponding options ideas we feel have the potential to perform well:

Ford Motor Co. (F) – Ford set record North American profits and beat Wall St. expectations handily this morning. The stock is gapping up moderately, so we’re going to taking a look at F Weekly $14.50 and $15 Calls, which should produce some nice action.

Pfizer, Inc. PFE –  Pfizer also had an earnings beat on their Q2 release today, and our related options ideas will be to monitor PFE Weekly $34.50 and $35 Calls.

Baidu, Inc. BIDU – After an extreme analyst downgrade, BIDU is taking an absolute beating, and is leading us to include a rare idea on the bearish side of things; we’ll be tracking BIDU Weekly Puts in the $180-175 Range.

Cytori Therapeutics, Inc. CYTX

We also want to raise a flag on a familiar stock cropping up in the news feed this morning. Early this year we saw CYTX make a huge move, and after spending the last several months in a general downtrend, some FDA-related news out this morning could be just the thing to catalyze a reversal. We’ll be watching intently for that possibility; check out the news below.

Cytori Therapeutics, Inc. (CYTX) today announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia). >> FULL PR

Extended Watchlist:
PGNX, SDRL, NYMX, AKS, RJET

Blue Horseshoe Stocks: Late-Breaking PZOO News

Pazoo, Inc. PZOO

For those of our subscribers who may have missed our after hours highlight of PZOO‘s post-market PR yesterday, it alluded to the signing of Pazoo subsidiary CannabisKing’s second distribution deal in as many weeks. The company has obtained the rights to distribute Grow Pure Systems™ full product line >> VIEW PR We had also tagged the stock in our premarket extended watchlist as a bottom-watch play, and it did make a solid 14% intraday move from .0057-.0065.

We’ve already seen PZOO make a couple of more serious swings from the subpenny range to .015 or better back in April and May, so we’re well aware of its ability to make rapid gains. It is being demonstrated once again this morning, as PZOO shot to a high of .0099, running into resistance just shy of the 50DMA (.01); that’s a two-session swing of 74% over yesterday’s low!

That combined with  three significant news releases over the past 24 hours, puts our focus squarely on PZOO as we wrap up another trading week, and will surely make it a point of interest heading into next week as well.

Late-breaking news from PZOO this morning just hit the wires and it outlines a third distribution agreement for its CannabisKing subsidiary, which is increasing its portfolio at an impressive rate:

WHIPPANY, N.J., July 10, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK), 100% wholly owned subsidiary CannabisKing Distribution, LLC, has signed a deal with MJPayment, LLC, to sell their Banking Solution Services throughout the region where Pazoo labs are being opened. MJPayment has developed an innovative and powerful payment and banking suite as well as an industry first bank compliance solution for the legal marijuana industry. >> FULL PR

Blue Horseshoe Stocks: PZOO Post-Market News

Pazoo, Inc. PZOO

We wanted to send out an afternoon update on PZOO after noticing a new PR hitting the wires after hours today. We tagged the stock as a bottom-watch play in this morning’s extended watchlist, noting that it had been flirting with 3-month lows. PZOO responded by producing a respectable 14% intraday move from .0057-.0065, and holding the majority of its ground with a .0063 close.

Those of our readers that have been following Pazoo’s story along with us recently will recall PZOO’s subsidiary, CannabisKing Distribution, which was formed this spring. The company appears to be making steady strides in the development of this branch of its business over the past couple of weeks. On June 25th, they announced that CannabisKing struck a distribution deal for Accuvape vaporizers and accesories. Today, we’re learning that the rights have been acquired to distribute a sanitation system for legal marijuana grow operations that evidently kills mold, mildew and all sorts of harmful pathogens that can ruin a crop.

We suggest our readers take a look at the PR, and continue to stay tuned for further updates on PZOO:

WHIPPANY, N.J., July 9, 2015 /PRNewswire/ — Pazoo, Inc. (PZOO) announced today it has signed a distribution agreement with Pure Grow Systems, LLC, a subsidiary of FastFunds Financial Corporation (FFFC). The terms of the agreement give Pazoo the right to distribute the Pure Grow Systems product line to cannabis-related companies in select states in the United States. >> FULL PR

Blue Horseshoe Stocks: DRMC Review & More

Definitive Rest Mattress Co. DRMC

To start things off this morning we wanted to provide an update on DRMC, which made an excellent intraday move to start the session yesterday.

When last we looked in on DRMC at the end of the short week on Thursday, we had just observed a decent 35% intraday run in the prior session, and left our readers with a closing thought that would end up serving us well. We noted that the stock had been trading relatively thinly as a general rule, and that “a pickup in buying pressure could really send DRMC for a ride, so we’ll keep watch for that, and for the stock to continue maintaining support above the 50DMA”

It’s a good thing that we did keep watch, because the stock would both maintain above the 50DMA (.002), and see the necessary surge in volume to make its mark. Starting out from a morning low of .0037, DRMC bulled its way up to a high of .0079 in roughly the first 45 minutes of trading. That worked out to an incredible single session rip totaling 113%  From our observed low on Tuesday (.0022), yesterday’s high registered as a two-session swing of 259%

The excellent spike in volume came in conjunction with the company’s announcement that it was adding Carbon Fiber to its list of manufacturing technologies, as well as launching its new website. >>View PR

Regen BioPharma, Inc. RGBP

RGBP is hitting our scanner this morning for a couple of reasons. Firstly, the company released a positive PR regarding one of its new drug candidates, HemaXellerate. The results of an animal study conducted at the behest of the FDA proved promising with regard to the treatment’s path to approval for clinical trials.

Secondly, RGBP represents a potential opportunity as a play trading near a recent relative bottom. We’re going to look for RGBP to record higher highs and higher lows. and hold support above Tuesday’s swing low of .12 in order for us to remain interested.

Extended Watchlist:
RMGN, FRO, MM, NQ, PZOO(Testing 3mo. Lows, on Bottom-Watch)

Get Our FREE Daily Reports!

SUBSCRIBE